AdhereTech: Reducing Disparities in Medication Adherence

AdhereTech is dedicated to addressing medication adherence disparities through innovative devices tailored to diverse populations. By leveraging smart technology and personalized interventions, AdhereTech strives to enhance medication adherence rates among young and elderly patients, patients from low socioeconomic backgrounds, racial and ethnic minorities, and patients residing in rural locations.? These populations often encounter unique challenges in managing their health, which AdhereTech’s tailored devices are designed to help mitigate. Although AdhereTech’s devices aim to reduce many adherence challenges, they are not a perfect solution, as no single approach can address all issues related to medication adherence among all populations. For instance, AdhereTech’s devices are designed for oral medications, meaning patients receiving injectables do not benefit from these products. Nonetheless, while recognizing the limitations of a one-size-fits-all solution, AdhereTech’s approach strives to improve individual health outcomes and align with broader public health goals, seeking to reduce the burden of chronic diseases and extensive annual healthcare costs.?

Enhancing Adherence Among Youth

AdhereTech addresses the unique challenges faced by adolescents with chronic conditions via innovative devices designed to enhance medication adherence. By utilizing smart technology and personalized interventions, AdhereTech aims to significantly improve adolescent adherence rates by providing tailored solutions that address their psychological, social, and developmental needs.

AdhereTech’s devices aim to enhance adolescent medication adherence by utilizing devices designed to remove patient burden. Visual and auditory alerts serve a crucial role in reminding patients to take their medication on time, reducing the need for constant vigilance from adolescents and caregivers while simultaneously helping to maintain consistent use. This method enhances adherence while alleviating concerns about forgetfulness or missed doses, contributing to a less burdensome and easier treatment experience for adolescent patients (El-Rachidi et al., 2017; Fiese & Everhart, 2006; KyngAs, 2000; Sawyer & Aroni, 2003). Moreover, these devices include extended battery life, allowing for reliable operation without the need for frequent charging and operate cellularly, eliminating the need for WiFi or bluetooth. By simplifying medication management, AdhereTech empowers adolescents to gain greater control over their health easily and confidently.?

AdhereTech’s smart devices utilize real-time data to monitor adherence and provide automated reminders to patients to take their medication. These reminders include initial visual and auditory alerts at the patient’s chosen dosage time and escalating to text messages or phone calls if a dosage is missed to heighten consistent medication adherence among patients. This helps to address elements such as forgetfulness and lack of routine that often contribute to nonadherence among adolescents. Notably, these missed dosage alerts can be sent to caregivers, allowing for timely intervention and providing an additional layer of encouragement and accountability for adolescents to remain adherent (Fiese & Everhart, 2006; Kalaman et al., 2023). By providing customized and recurring reminders, AdhereTech effectively empowers adolescents to develop the discipline necessary for managing their health independently while including caregivers for additional support in the treatment process.?

Furthermore, by providing these devices to patients at no additional cost through partnerships with pharmaceutical companies, AdhereTech helps to reduce the financial barriers that prevent adolescents from accessing necessary adherence support. This approach is particularly beneficial for adolescents from low socioeconomic groups, who may otherwise struggle to afford technologies designed to enhance their medication adherence (Wise, 2007). By removing financial barriers, AdhereTech ensures equitable access to its innovative adherence technology, priming better health outcomes across all socioeconomic backgrounds. This accessibility underscores the company’s commitment to support all patients, regardless of socioeconomic status, in effectively managing their chronic conditions.?

Moreover, AdhereTech’s commitment to supporting young patients is emphasized by utilizing text messages to connect with, support, and engage adolescents. Text messaging is the preferred method of communication for many adolescents. AdhereTech ensures adolescents conveniently receive timely medication reminders and support. This helps to foster ongoing engagement and empowers youth to manage their health by integrating healthcare into their daily lives seamlessly (Badawy et al., 2017). By enhancing communication with adolescent patients, AdhereTech promotes medication management and creates a supportive environment for them.

Overall, AdhereTech’s comprehensive approach to increasing medication adherence among youth combines innovative technology with personal support, addressing the nuances challenged adolescents with chronic conditions face. By enhancing adherence, AdhereTech contributes to better health outcomes and improved quality of life for young patients. This engages youth to effectively manage their conditions while minimizing the burden and anxiety associated with medication management in adolescents’ busy schedules and lifestyles.

Increasing Adherence Among Elderly Patients

AdhereTech's smart devices aim to increase medication adherence among elderly patients by addressing many of the pressing challenges outlined within the literature. These devices include easy-to-use technology to support patients in managing their medication regimens more effectively. For instance, these devices are designed to be user-friendly to simplify the complexity of medication management (Marcum & Gellad, 2012). This setup is critical as research suggests that technology can be intimidating to elderly adults, with a significant portion of those over the age of 65 reporting they feel uncomfortable and unfamiliar with technology (Holender et al., 2018). Two of the main concerns raised by this demographic included potential reductions in communication and technological failures (Holender et al., 2018). AdhereTech devices require no patient setup, no app installation, and function on cellular data to minimize technical difficulties for patients. Furthermore, by including automated reminders and having a support team monitor patient adherence at each dose, this ensures patients feel empowered to use these devices and feel supported.

These smart devices also provide crucial cognitive support for elderly patients. The devices require no extensive instructions for setup or when following their medication routine, which mitigates issues stemming from cognitive impairments (Campbell et al., 2016). A series of automated reminders are utilized, including lights and chimes, escalating to text messages or phone calls if the dose is missed, and assisting patients with cognitive decline in remembering to take their medication on time. In addition to cognitive support, these devices address sensory impairments by incorporating auditory and visual alerts (Alhusein et al., 2019; Salive, 2013). These alerts ensure that patients with visual or hearing impairments can receive and clearly understand their medication reminders.?

Furthermore, for patients with diseases causing physical limitations, such as arthritis, tremors, and other mobility issues, AdhereTech provides an easy-to-open cap upon request to ensure these patients can access their medication without any physical difficulties (Alhusein et al., 2019; Salive, 2013). Additionally, these devices have an extended battery life, minimizing the need for frequent recharging, which is crucial for patients with cognitive or physical limitations that prevent them from being able to charge their devices frequently. The effectiveness and innovative design of these devices have even been recognized by the Smithsonian Design Museum, which has included AdhereTech’s devices in its“Access+Ability” exhibition (AdhereTech, 2018).??

These devices also ensure a support system is in place to assist elderly patients if necessary by alerting caregivers and AdhereTech’s support team when a missed dose occurs. This proactive approach helps to maintain adherence by supporting elderly patients by providing crucial social support, alleviating depression, and enhancing adherence (Grenard et al., 2011; K et al., 2023). Hence, by integrating support networks, the devices provide elderly patients with necessary social support when required.?

Furthermore, smart devices come at no additional cost to patients. Hence, although they may not directly mitigate financial constraints, they serve as a cost-effective solution that can reduce overall healthcare costs by preventing complications and hospitalizations due to nonadherence (Poorcheraghi et al., 2023). This indirect financial relief can ease the burden placed on elderly patients. Additionally, the devices enhance psychosocial support by connecting patients and healthcare teams when missed doses occur, reducing feelings of isolation (Holvast et al., 2019; Grenard et al., 2011).?

AdhereTech’s smart devices offer a comprehensive solution to many factors contributing to medication nonadherence in elderly patients. By simplifying medication management, providing cognitive and physical support, addressing sensory impairments, and fostering better communication, these devices help ensure that elderly patients adhere to their prescribed medication regimens, improving their overall health outcomes.

Supporting Low Socioeconomic Status (SES) Patients

AdhereTech's smart devices offer promising solutions for improving medication adherence among patients of low socioeconomic status (SES), who may experience high rates of nonadherence due to economic, educational, and social barriers. These devices utilize sophisticated, but patient-friendly technology to address the specific needs of this population.

Economic constraints are the predominant barrier for low SES patients, as they often have difficulty affording medications, regardless of insurance coverage. High out-of-pocket payments, including deductibles and copayments, deter patients from filling prescriptions or adhering to long-term medication regimens (Briesacher et al., 2007; Wenger et al., 2016). AdhereTech’s smart devices can mitigate some of these economic barriers by improving adherence, which leads to better health outcomes, potentially lowering healthcare costs overall. By reducing complications and hospitalizations, these devices can indirectly reduce some financial burdens on patients (Poorcheraghi et al., 2023). Furthermore, these devices come at no additional cost for patients, providing patients with real-time monitoring and reminders that enhance adherence free of charge to the patient. These devices come fully equipped and ready to use, including a charger, to mitigate additional costs and increase accessibility the moment they arrive. Additionally, when patients inform AdhereTech of financial concerns regarding affording their medication, AdhereTech facilitates proactive assistance. Patient cost concerns are escalated to the specialty pharmacy or care team, who work with patients to connect them with financial assistance resources to ensure they do not have to discontinue their medication due to costs. This approach ensures that economic barriers do not prevent patients from accessing the tools they need to maintain consistent medication adherence.?

Educational barriers also play a critical role in medication nonadherence among low SES populations. Lower levels of health literacy are common among this population, leading to misunderstandings about medication directions? (Gazmararian et al., 2003; Miller, 2016). AdhereTech’s smart devices help address educational challenges by providing clear, easily accessible medication reminders.?

Social factors, such as unstable living conditions and lack of social support, further exacerbate nonadherence among low SES individuals. Those experiencing housing instability or homelessness face additional challenges to consistent medication adherence and having consistent access to their medications (Baggett et al., 2010; Fernandez et al., 2022). AdhereTech’s smart devices function on cellular data, supporting patients by providing consistent reminders and alerts without needing WiFi, Bluetooth, or a smartphone. This can be crucial for maintaining adherence despite unstable living conditions. Moreover, the devices can facilitate connections with the AdhereTech healthcare team when necessary, offering social support that encourages and assists patients in managing their medication needs (DiMatteo, 2004; Shahin et al., 2021). Unlike other smart devices or apps that require patients to use a smartphone, AdhereTech’s system ensures accessibility without needing a smartphone, making it more inclusive and practical for patients facing socioeconomic difficulties.?

Transportation barriers significantly impact medication adherence in low SES populations. Patients with inconsistent transportation may struggle to travel to pharmacies or medical appointments for additional support, leading to missed doses and inconsistent treatment (Syed et al., 2013; Wolfe et al., 2020). AdhereTech’s smart devices can help mitigate these barriers by ensuring patients receive timely reminders and support for their medication regimens, reducing the need for frequent trips to the pharmacy. Furthermore, AdhereTech’s support team can trigger auto refills when a patient notifies the AdhereTech support team that their medication is reaching low levels. This results in the care team notifying the patient’s specialty pharmacy to auto-refill the prescription and ship this refill to patients to ensure patients have consistent access to their medication. In addition to these benefits, AdhereTech’s devices have a battery life of up to ten months, with ongoing monitoring by AdhereTech’s support team, who encourages patients to recharge their devices when the battery begins to run low via the provided charger. This proactive approach helps to ensure patients’ medication adherence remains uninterrupted while eliminating the burden of needing to travel to healthcare facilities for battery replacements.?

In conclusion, AdhereTech's smart devices offer comprehensive solutions to the multifaceted barriers contributing to medication nonadherence among low socioeconomic status patients. By improving affordability, accessibility, and social support, these devices can significantly enhance medication adherence and overall health outcomes for this population. Addressing these challenges with patient-friendly technology like smart devices is crucial for reducing current health disparities and enhancing the quality of care for individuals of low socioeconomic status.

Enhancing Medication Compliance Among Racial and Ethnic Minorities

AdhereTech addresses multiple disparities in medication adherence for racial and ethnic minorities by leveraging technology to overcome socioeconomic, cultural, and systemic barriers that disproportionately affect minority populations. For instance, AdhereTech’s smart pill bottles address socioeconomic barriers by improving access to medication and healthcare services. These devices, provided at no additional cost to patients by partnering with pharmaceutical companies, feature simple, patient-friendly technology that offers real-time monitoring and reminders. This is critical for patients with financial constraints that may lead to inconsistent adherence. By supplying these devices free of charge to patients through pharmaceutical sponsorships, AdhereTech helps alleviate the financial burden placed on patients, enabling them to prioritize their health without making difficult choices between purchasing devices to enhance their adherence and meeting other essential needs (Dong et al., 2021; McQuaid & Landier, 2018).?

To address cultural and linguistic barriers, AdhereTech’s reminder system and live support healthcare team includes multilingual support, currently including Spanish, with plans to include additional languages. This ensures patients receive reminders and instructions on how to use their device in their preferred language, reducing the risk of misunderstandings and promoting better adherence (Anderson & Bulato, 2024; Ngo-Metzger et al., 2007). Furthermore, AdhereTech combats systemic issues such as implicit bias and discrimination by providing equitable technology-based adherence support uninfluenced by bias. This technology ensures consistent and unbiased delivery of care and adherence reminders, fostering trust among minority patients who might otherwise be skeptical of the healthcare system due to past experiences of lower-quality care or discrimination (Anderson & Bulato, 2024; Centers for Disease Control and Prevention, 2022; Kressin et al., 2001).?

Notably, many minority patients often lack regular sources of care. AdhereTech’s technology provides a stable and continuous link between patients and providers. These smart devices enable effective monitoring with remote coverage, contacting patients when missed doses occur to maintain a consistent treatment plan, which is essential for managing conditions effectively (Doty et al., 2018). Unlike other systems that provide frequent reminders regardless of adherence, AdhereTech’s devices only escalate and highlight nonadherence once it occurs. This means that if a patient is adherent, they will not be bothered until their next dose is due, avoiding unnecessary notifications while ensuring timely interventions without causing undue stress. Additionally, these devices are equipped with a battery life of up to ten months on a single charge, reducing the need for frequency charging. This feature further enhances convenience and mitigates unnecessary disruptions in medication management, supporting consistent adherence.

AdhereTech’s technology-driven approach directly addresses the multifaceted challenges faced by racial and ethnic minority patients in adhering to medication regimens. By enhancing access to care, bridging cultural and linguistic gaps, addressing systematic inequalities, and improving continuity of care, AdhereTech provides a comprehensive solution that promotes equity in healthcare and supports better health outcomes for minority populations.

Bridging the Gap for Rural Patients

AdhereTech’s innovative devices are designed to mitigate the barriers to medication adherence faced by patients in rural areas, addressing geographic, economic, and systematic challenges. AdhereTech’s smart pill devices alleviate the travel burdens associated with medication adherence in rural areas. By providing real-time monitoring and automated reminders, these devices reduce the need for frequent trips to healthcare facilities. Patients receive timely notifications regarding their medication schedules, minimizing the need for in-person visits to manage their adherence. This is especially beneficial in rural locations where limited public transportation and long travel distances make regular visits challenging (Worth & Pathman, 2006; Xu et al., 2021).?

To address the economic barriers that impede medication adherence, AdhereTech's devices come at no additional cost to patients. This removes the financial burden associated with acquiring advanced adherence technology, making it accessible to those in rural areas who may have lower income levels and limited insurance coverage. By ensuring that these technologies are financially accessible, AdhereTech helps patients manage their medication without the added pressure of additional costs (Xu et al., 2021).?

AdhereTech’s technology also improves support for rural patients by incorporating features that assist in overcoming local healthcare limitations. The device's real-time data tracking allows AdhereTech’s support team to remotely monitor patients’ adherence, reducing the need for frequent in-person checkups.? This remote monitoring is critical in areas with fewer local pharmacies and specialized facilities, ensuring continuous and effective management of chronic conditions (Chai et al., 2021). Notably, even if a patient is in an area without cellular coverage, these devices can store up to 500 readings and automatically download them when a patient returns to cellular coverage to ensure no data is lost. Additionally, the devices have a battery life of up to ten months, and AdhereTech’s healthcare team monitors the battery levels. They encourage patients to recharge their devices when the battery is low using the provided charger. This proactive approach is critical for patients residing in rural areas, as it ensures uninterrupted use of the devices, maintaining consistent health monitoring and management without the burden of frequent travel to healthcare facilities.?

AdhereTech effectively addresses the multifaceted challenges of medication nonadherence in rural areas through its advanced technology. By reducing geographic barriers, alleviating economic challenges, and enhancing systematic support, AdhereTech ensures patients in rural areas have the tools to adhere to their medication regimens consistently. This comprehensive approach contributes to better health outcomes and quality of life for patients residing within rural locations.

References

AdhereTech. (2018, January 10). AdhereTech’s smart pill bottle is on display at Cooper Hewitt, Smithsonian Design Museum. AdhereTech Blog. https://blog.adheretech.com/post/170870553715/adheretechs-smart-pill-bottle-is-on-display.?

Alhusein, N., Killick, K., Macaden, L., Smith, A., Stoddart, K., Taylor, A., Kroll, T., & Watson, M. C. (2019). "We're really not ready for this": A qualitative exploration of community pharmacy personnel's perspectives on the pharmaceutical care of older people with sensory impairment. Disability and health journal, 12(2), 242–248. https://doi.org/10.1016/j.dhjo.2018.10.006.?

Anderson, N. B., & Bulatao, R. A. (Eds.). (2004). Understanding racial and ethnic differences in health in late life: a research agenda. National Library of Medicine.

Baggett, T. P., O'Connell, J. J., Singer, D. E., & Rigotti, N. A. (2010). The unmet health care needs of homeless adults: a national study. American journal of public health, 100(7), 1326-1333. https://doi.org/10.2105/AJPH.2009.180109.?

Barber, N., Parsons, J., Clifford, S., Darracott, R., & Horne, R. (2004). Patients’ problems with new medication for chronic conditions. BMJ Quality & Safety, 13(3), 172-175. https://doi.org/10.1136/qshc.2003.005926.?

Badawy, S. M., Barrera, L., Sinno, M. G., Kaviany, S., O'Dwyer, L. C., & Kuhns, L. M. (2017). Text Messaging and Mobile Phone Apps as Interventions to Improve Adherence in Adolescents With Chronic Health Conditions: A Systematic Review. JMIR mHealth and uHealth, 5(5), e66. https://doi.org/10.2196/mhealth.7798.?

Briesacher, B. A., Gurwitz, J. H., & Soumerai, S. B. (2007). Patients at-risk for cost-related medication nonadherence: a review of the literature. Journal of general internal medicine, 22, 864-871. https://doi.org/10.1007/s11606-007-0180-x.?

Campbell, N. L., Boustani, M. A., Skopelja, E. N., Gao, S., Unverzagt, F. W., & Murray, M. D. (2012). Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. The American journal of geriatric pharmacotherapy, 10(3), 165-177. https://doi.org/10.1016/j.amjopharm.2012.04.004.?

Centers for Disease Control and Prevention. (2022). The U.S. Public Health Service syphilis study at Tuskegee timeline. U.S. Department of Health and Human Services. https://www.cdc.gov/tuskegee/timeline.htm.?

Chai, X., Liu, Y., Mao, Z., & Li, S. (2021). Barriers to medication adherence for rural patients with mental disorders in eastern China: a qualitative study. BMC Psychiatry, 21, 1-8. https://doi.org/10.1186/s12888-021-03144-y.?

DiMatteo, M. R. (2004). Social Support and Patient Adherence to Medical Treatment: A Meta-Analysis. Health Psychology, 23(2), 207–218. https://doi.org/10.1037/0278-6133.23.2.207.?

Dong, X., Tsang, C. C. S., Wan, J. Y., Shih, Y. T., Chisholm-Burns, M. A., Dagogo-Jack, S., Cushman, W. C., Hines, L. E., & Wang, J. (2021). Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients. Exploratory research in clinical and social pharmacy, 3, 100041. https://doi.org/10.1016/j.rcsop.2021.100041.?

Doty, M. M., Tikkanen, R., Shah, A., & Schneider, E. C. (2020). Primary Care Physicians’ Role In Coordinating Medical And Health-Related Social Needs In Eleven Countries: Results from a 2019 survey of primary care physicians in eleven high-income countries about their ability to coordinate patients’ medical care and with social service providers. Health Affairs, 39(1), 115-123. https://doi.org/10.1377/hlthaff.2019.01088.?

El-Rachidi, S., LaRochelle, J. M., & Morgan, J. A. (2017). Pharmacists and Pediatric Medication Adherence: Bridging the Gap. Hospital pharmacy, 52(2), 124–131. https://doi.org/10.1310/hpj5202-124/.?

Fernandez, S. B., Lopez, C., Ibarra, C., Sheehan, D. M., Ladner, R. A., & Trepka, M. J. (2022). Examining Barriers to Medication Adherence and Retention in Care among Women Living with HIV in the Face of Homelessness and Unstable Housing. International journal of environmental research and public health, 19(18), 11484. https://doi.org/10.3390/ijerph191811484.?

Fiese, B. H., & Everhart, R. S. (2006). Medical adherence and childhood chronic illness: family daily management skills and emotional climate as emerging contributors. Current opinion in pediatrics, 18(5), 551-557. Doi: 10.1097/01.mop.0000245357.68207.9.?

Gazmararian, J. A., Williams, M. V., Peel, J., & Baker, D. W. (2003). Health literacy and knowledge of chronic disease. Patient education and counseling, 51(3), 267-275. https://doi.org/10.1016/S0738-3991(02)00239-2.?

Grenard, J. L., Munjas, B. A., Adams, J. L., Suttorp, M., Maglione, M., McGlynn, E. A., & Gellad, W. F. (2011). Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. Journal of general internal medicine, 26, 1175-1182. https://doi.org/10.1007/s11606-011-1704-y.?

Holender, A., Sutton, S., & De Simoni, A. (2018). Opinions on the use of technology to improve tablet taking in> 65-year-old patients on cardiovascular medications. Journal of International Medical Research, 46(7), 2754-2768. https://doi.org/10.1177/0300060518770578.?

Holvast, F., Oude Voshaar, R. C., Wouters, H., Hek, K., Schellevis, F., Burger, H., & Verhaak, P. F. (2019). Non-adherence to antidepressants among older patients with depression: a longitudinal cohort study in primary care. Family practice, 36(1), 12-20., 17, 1641–1656. https://doi.org/10.2147/PPA.S380784.?

K, J., Rao, M., Yn, S., Thunga, G., N, R., Sudhakar, C., & Sanatombi Devi, E. (2023). Determinants of Medication Non-Adherence Among the Elderly with Co-Existing Hypertension and Type 2 Diabetes Mellitus in Rural Areas of Udupi District in Karnataka, India. Patient preference and adherence, 17, 1641–1656. https://doi.org/10.2147/PPA.S380784.?

Kalaman, C. R., Ibrahim, N., Shaker, V., Cham, C. Q., Ho, M. C., Visvalingam, U., Shahabuddin, F. A., Abd Rahman, F. N., A Halim, M. R. T., Kaur, M., Azhar, F. L., Yahya, A. N., Sham, R., Siau, C. S., & Lee, K. W. (2023). Parental Factors Associated with Child or Adolescent Medication Adherence: A Systematic Review. Healthcare (Basel, Switzerland), 11(4), 501. https://doi.org/10.3390/healthcare11040501.?

Kressin, N. R., & Petersen, L. A. (2001). Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Annals of internal medicine, 135(5), 352-366. https://www.acpjournals.org/doi/full/10.7326/0003-4819-135-5-200109040-00012.?

KyngAs, H. A., Kroll, T., & Duffy, M. E. (2000). Compliance in adolescents with chronic diseases: a review. The Journal of adolescent health : Official publication of the Society for Adolescent Medicine, 26(6), 379–388. https://doi.org/10.1016/s1054-139x(99)00042-7.?

Marcum, Z. A., & Gellad, W. F. (2012). Medication adherence to multidrug regimens. Clinics in geriatric medicine, 28(2), 287-300. https://doi.org/10.1016/j.cger.2012.01.008.?

McQuaid, E. L., & Landier, W. (2018). Cultural issues in medication adherence: disparities and directions. Journal of General Internal Medicine, 33, 200-206. https://doi.org/10.1007/s11606-017-4199-3.?

Miller T. A. (2016). Health literacy and adherence to medical treatment in chronic and acute illness: A meta-analysis. Patient education and counseling, 99(7), 1079–1086. https://doi.org/10.1016/j.pec.2016.01.020.?

Ngo-Metzger, Q., Sorkin, D. H., Phillips, R. S., Greenfield, S., Massagli, M. P., Clarridge, B., & Kaplan, S. H. (2007). Providing high-quality care for limited English proficient patients: the importance of language concordance and interpreter use. Journal of general internal medicine, 22, 324-330. https://doi.org/10.1007/s11606-007-0340-z.?

Poorcheraghi, H., Negarandeh, R., Pashaeypoor, S., & Jorian, J. (2023). Effect of using a mobile drug management application on medication adherence and hospital readmission among elderly patients with polypharmacy: a randomized controlled trial. BMC Health Services Research, 23(1), 1192. https://doi.org/10.1186/s12913-023-10177-4.?

Salive, M. E. (2013). Multimorbidity in older adults. Epidemiologic reviews, 35(1), 75-83. https://doi.org/10.1093/epirev/mxs009.?

Sawyer, S. M., & Aroni, R. A. (2003). Sticky issue of adherence. Journal of Paediatrics and Child Health, 39(1), 2-5. https://doi.org/10.1046/j.1440-1754.2003.00081.x.?

Shahin, W., Kennedy, G. A., & Stupans, I. (2021). The association between social support and medication adherence in patients with hypertension: A systematic review. Pharmacy practice, 19(2), 2300. https://doi.org/10.18549/PharmPract.2021.2.2300.?

Syed, S. T., Gerber, B. S., & Sharp, L. K. (2013). Traveling towards disease: transportation barriers to health care access. Journal of Community Health, 38, 976-993. https://doi.org/10.1007/s10900-013-9681-1.?

Wenger, L. M., Rosenthal, M., Sharpe, J. P., & Waite, N. (2016). Confronting inequities: a scoping review of the literature on pharmacist practice and health-related disparities. Research in Social and Administrative Pharmacy, 12(2), 175-217. https://doi.org/10.1016/j.sapharm.2015.05.011.?

Wise P. H. (2007). The future pediatrician: the challenge of chronic illness. The Journal of Pediatrics, 151(5 Suppl), S6–S10. https://doi.org/10.1016/j.jpeds.2007.08.013.?

Wolfe, M. K., McDonald, N. C., & Holmes, G. M. (2020). Transportation Barriers to Health Care in the United States: Findings From the National Health Interview Survey, 1997-2017. American journal of public health, 110(6), 815–822. https://doi.org/10.2105/AJPH.2020.305579.?

Wroth, T. H., & Pathman, D. E. (2006). Primary medication adherence in a rural population: the role of the patient-physician relationship and satisfaction with care. The Journal of the American Board of Family Medicine, 19(5), 478-486. https://doi.org/10.3122/jabfm.19.5.478.?

Xu, J., Zhao, M., Vrosgou, A., Yu, N. C. W., Liu, C., Zhang, H., ... & Bettger, J. P. (2021). Barriers to medication adherence in a rural-urban dual economy: a multi-stakeholder qualitative study. BMC Health Services Research, 21, 1-9. https://doi.org/10.1186/s12913-021-06789-3.